Xylem (NYSE: XYL) reported Q3 EPS of $1.37, $0.14 better than the analyst estimate of $1.23. Revenue for the quarter came in at $2.3 billion versus the consensus estimate of $2.22 billion.

GUIDANCE:

Xylem sees FY2025 revenue of $9 billion, versus the consensus of $8.95 billion.

For earnings history and earnings-related data on Xylem (XYL) click here.